Safety and Immunogenicity of 1 or 2 Additional Doses of the Adjuvanted Recombinant Zoster Vaccine Administered 5–6 Years After Primary Vaccination in Adults ≥50 Years.
Saved in:
| Title: | Safety and Immunogenicity of 1 or 2 Additional Doses of the Adjuvanted Recombinant Zoster Vaccine Administered 5–6 Years After Primary Vaccination in Adults ≥50 Years. |
|---|---|
| Authors: | Leon, Rafael1 (AUTHOR), Diez-Domingo, Javier2 (AUTHOR), Andrews, Charles3 (AUTHOR), Cunha, Clovis Arns da4 (AUTHOR), Choo, Eun-Ju5 (AUTHOR), Hui, David Shu Cheong6 (AUTHOR), Cunningham, Anthony L7 (AUTHOR), Eto, Takashi8 (AUTHOR), Icardi, Giancarlo9 (AUTHOR), McNeil, Shelly A10 (AUTHOR) |
| Source: | Open Forum Infectious Diseases. Jun2026, Vol. 13 Issue 6, p1-12. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
